Publication Venue For
Potential kidney toxicity from the antiviral drug tenofovir: New indications, new formulations, and a new prodrug
The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
Endothelin-1 and the kidney: New perspectives and recent findings
Pathophysiology of the chronic kidney disease - Mineral bone disorder
Current status on the evaluation and management of the highly sensitized kidney transplant recipient
Medical management of chronic kidney disease in the renal transplant recipient
Pathogenesis of immunoglobulin A nephropathy
Nitric oxide and the A and B of endothelin of sodium homeostasis
Fibroblast growth factor 23 and the heart
Increased serum phosphate and adverse clinical outcomes: Unraveling mechanisms of disease
Mechanisms and consequences of salt sensitivity and dietary salt intake
Uric acid: A novel mediator and marker of risk in chronic kidney disease?
Tubuloglomerular feedback mechanisms in nephron segments beyond the macula densa
Renin inhibition: Should it supplant ACE inhibitors and ARBS in high risk patients?
Endothelin and NOS1/nitric oxide signaling and regulation of sodium homeostasis
Vascular stenosis: Biology and interventions
Effect of salt intake on progression of chronic kidney disease
Hormonal and cytokine effects of uric acid
Fabry disease: Diagnosis and management, with emphasis on the renal manifestations
Management of paraproteinemic renal disease
IgA nephropathy: An update
A family of calcium-permeable channels in the kidney: Distinct roles in renal calcium handling
Hormone replacement therapy and hypertension
Genetic forms of human hypertension
Interaction of syntaxins with epithelial ion channels
Renal endothelin in hypertension
Sodium transporters in health and disease
Antihypertensive therapy in the era of evidence based medical practice: What to do until the facts are in
Hypertension in postmenopausal women: Pathophysiology and management
Hypertension in women
Antihypertensive therapy in the context of total cardiovascular risk: the rational basis for therapeutic recommendations.
Neurologic consequences of hypertension and antihypertensive drug therapy.
Renal involvement in plasma cell dyscrasias.
The role of the sympathetic nervous system in hypertension.